AZN / USDNYSEEquity Info
P/E Ratio24.45
Market Cap$253.3B
EPS6.68
52 Week Range$144.18 - $209.11
Volume$3.74M
Liquidity Score6
About AstraZeneca PLC
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Websitewww.astrazeneca.com
HeadquartersCAMBRIDGE, UNITED KINGDOM
Related News
1/5
Seeking Alpha 1d agoAstraZeneca wins EU label expansion for Trixeo in asthma (AZN)
No image available
Yahoo Finance Australia 1d agoAstraZeneca's Trixeo Secures Approval for Asthma in the EU
Stock Titan 1d agoEU clears first triple-therapy asthma medicine from AstraZeneca (AZN)
No image available
TradingView 1d agoREG - AstraZeneca PLC - Trixeo approved in EU for asthma
No image available
DirectorsTalk Interviews 2d agoAstraZeneca PLC (AZN) Stock Analysis: Is A 27.75% Upside On The Horizon?
No image available
Stock Titan 5d agoAstraZeneca (AZN) CEO buys 60,000 shares in LON trade
No image available
Assets
Trending